{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T11:02:29Z","timestamp":1710500549099},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2008,8,8]],"date-time":"2008-08-08T00:00:00Z","timestamp":1218153600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1007\/s00120-008-1843-x","type":"journal-article","created":{"date-parts":[[2008,8,6]],"date-time":"2008-08-06T15:59:56Z","timestamp":1218038396000},"page":"1465-1471","source":"Crossref","is-referenced-by-count":3,"title":["Botulinumtoxin in der Therapie der benignen Prostatahyperplasie"],"prefix":"10.1007","volume":"47","author":[{"given":"S.","family":"Boy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Seif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. M.","family":"Braun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.-P.","family":"J\u00fcnemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,8,8]]},"reference":[{"key":"1843_CR1","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/01.ju.0000078083.38675.79","volume":"170","author":"AUA","year":"2003","unstructured":"AUA guideline on management of benign prostatic hyperplasia (2003) Chapter 1: Diagnosis and treatment recommendations. J Urol 170: 530\u2013547","journal-title":"J Urol"},{"key":"1843_CR2","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.eururo.2005.12.010","volume":"49","author":"Apostolidis","year":"2006","unstructured":"Apostolidis A, Dasgupta P, Fowler CJ (2006) Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity. Eur Urol 49: 644\u2013650","journal-title":"Eur Urol"},{"key":"1843_CR3","first-page":"2501","volume":"104","author":"Berges","year":"2007","unstructured":"Berges R, Muschter R, H\u00f6fner K (2007) Alternative, minimalinvasive Therapien beim benignen Prostatasyndrom: Teil 4 der Serie zum benignen Prostatasyndrom. Dtsch Arztebl 104: 2501\u20132510","journal-title":"Dtsch Arztebl"},{"key":"1843_CR4","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.eururo.2007.03.030","volume":"52","author":"Choo","year":"2007","unstructured":"Choo MS (2007) Investigating botulinum toxin a on the functional properties of the prostate. Eur Urol 52: 324\u2013325","journal-title":"Eur Urol"},{"key":"1843_CR5","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.urology.2005.04.029","volume":"66","author":"Chuang","year":"2005","unstructured":"Chuang YC, Chiang PH, Huang CC et al. (2005) Botulinum toxin type A improves benign prostatic hyperplasia symptoms in patients with small prostates. Urology 66: 775\u2013779","journal-title":"Urology"},{"key":"1843_CR6","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/j.1464-410X.2006.06479.x","volume":"98","author":"Chuang","year":"2006","unstructured":"Chuang YC, Chiang PH, Yoshimura N et al. (2006a). Sustained beneficial effects of intraprostatic botulinum toxin type A on lower urinary tract symptoms and quality of life in men with benign prostatic hyperplasia. BJU Int 98: 1033\u20131037","journal-title":"BJU Int"},{"key":"1843_CR7","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0022-5347(05)00318-6","volume":"175","author":"Chuang","year":"2006","unstructured":"Chuang YC, Huang CC, Kang HY et al. (2006b) Novel action of botulinum toxin on the stromal and epithelial components of the prostate gland. J Urol 175: 1158\u20131163","journal-title":"J Urol"},{"key":"1843_CR8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2490-6-12","volume":"6","author":"Chuang","year":"2006","unstructured":"Chuang YC, Tu CH, Huang CC et al. (2006c) Intraprostatic injection of botulinum toxin type-A relieves bladder outlet obstruction in human and induces prostate apoptosis in dogs. BMC Urol 6: 12","journal-title":"BMC Urol"},{"key":"1843_CR9","doi-asserted-by":"crossref","unstructured":"Chuang YC, Yoshimura N, Huang CC et al. (2007) Intraprostatic botulinum toxin a injection inhibits cox-2 expression and suppresses prostatic pain on capsaicin induced prostatitis model in rat. American Urological Association (AUA) 2007 Annual Meeting, Anaheim, CA","DOI":"10.1016\/S0022-5347(18)30359-8"},{"key":"1843_CR10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/(SICI)1097-0045(19980915)37:1<44::AID-PROS7>3.0.CO;2-8","volume":"37","author":"Doggweiler","year":"1998","unstructured":"Doggweiler R, Zermann DH, Ishigooka M, Schmidt RA (1998) Botox-induced prostatic involution. Prostate 37: 44\u201350","journal-title":"Prostate"},{"key":"1843_CR11","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0022-5347(17)42717-0","volume":"139","author":"Dykstra","year":"1998","unstructured":"Dykstra DD, Sidi AA, Scott AB et al. (1998) Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients. J Urol 139: 919\u2013922","journal-title":"J Urol"},{"key":"1843_CR12","doi-asserted-by":"crossref","unstructured":"Guercini F, Giannantoni A, Bard RL et al. (2005) Intraprostatic botulin toxin injection in patients with severe benign prostatic hyperplasia: a multicenter feasibility study. American Urological Association AUA 2005 Annual Meeting, San Antonio, TX","DOI":"10.1016\/S0022-5347(18)35521-6"},{"key":"1843_CR13","first-page":"2424","volume":"104","author":"H\u00f6fner","year":"2007","unstructured":"H\u00f6fner K, Tunn UW, Reich O, R\u00fcbben H (2007) Operative Therapie des benignen Prostatasyndroms: Teil 3 der Serie zum benignen Prostatasyndrom. Dtsch Arztebl 104: 2424\u20132429","journal-title":"Dtsch Arztebl"},{"key":"1843_CR14","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.urology.2004.10.077","volume":"65","author":"Kuo","year":"2005","unstructured":"Kuo HC (2005) Prostate botulinum A toxin injection\u2013an alternative treatment for benign prostatic obstruction in poor surgical candidates. Urology 65: 670\u2013674","journal-title":"Urology"},{"key":"1843_CR15","doi-asserted-by":"crossref","unstructured":"Kuo HC (2007) Therapeutic effect of botulinum toxin A on large benign prostatic hyperplasia with persistent lower urinary tract symptoms and suboptimal treatment outcome of combination medical therapy \u2013 clinical and histological investigation of effects. American Urological Association (AUA) 2007 Annual Meeting, Anaheim, CA","DOI":"10.1016\/S0022-5347(18)32009-3"},{"key":"1843_CR16","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0022-5347(18)35520-4","volume":"173","author":"Larson","year":"2005","unstructured":"Larson TR (2005) Intraprostatic injection of botulinum toxin in the treatment of symptomatic LUTS, including sequential MRIS for accurate changes in size of the prostate. J Urol 173: 376\u2013377","journal-title":"J Urol"},{"key":"1843_CR17","first-page":"3","volume":"7","author":"Lepor","year":"20005","unstructured":"Lepor H (20005) Pathophysiology of lower urinary tract symptoms in the aging male population. Rev Urol 7(Suppl 7): 3\u201311","journal-title":"Rev Urol"},{"key":"1843_CR18","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.eururo.2007.03.002","volume":"52","author":"Lin","year":"2007","unstructured":"Lin AT, Yang AH, Chen KK (2007) Effects of botulinum toxin a on the contractile function of dog prostate. Eur Urol 52: 582\u2013589","journal-title":"Eur Urol"},{"key":"1843_CR19","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0090-4295(03)00477-1","volume":"62","author":"Maria","year":"2003","unstructured":"Maria G, Brisinda G, Civello IM et al. (2003) Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebo-controlled study. Urology 62: 259\u2013265","journal-title":"Urology"},{"key":"1843_CR20","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3349\/ymj.2006.47.5.706","volume":"47","author":"Park","year":"2006","unstructured":"Park DS, Cho TW, Lee YK et al. (2006) Evaluation of short term clinical effects and presumptive mechanism of botulinum toxin type A as a treatment modality of benign prostatic hyperplasia. Yonsei Med J 47: 706\u2013714","journal-title":"Yonsei Med J"},{"key":"1843_CR21","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1056\/NEJM198904273201705","volume":"320","author":"Roos","year":"1989","unstructured":"Roos NP, Wennberg JE, Malenka DJ et al. (1989) Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med 320: 1120\u20131124","journal-title":"N Engl J Med"},{"key":"1843_CR22","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2165\/00003495-200666100-00001","volume":"66","author":"Schurch","year":"2006","unstructured":"Schurch B (2006) Botulinum toxin for the management of bladder dysfunction. Drugs 66: 1301\u20131318","journal-title":"Drugs"},{"key":"1843_CR23","unstructured":"St\u00f6hrer M, Schurch B, Kramer G (1999) Botulinum A-Toxin in the treatment of detrusor hyperreflexia in spinal cord injured patients: a new alternative to medical and surgical procedures? 29th Annual Meeting of the International Continence Society, Denver, USA"},{"key":"1843_CR24","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJM199608223350809","volume":"335","author":"Walsh","year":"1996","unstructured":"Walsh PC (1996) Treatment of benign prostatic hyperplasia. N Engl J Med 335: 586\u2013587","journal-title":"N Engl J Med"},{"key":"1843_CR25","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/01.ju.0000155709.37840.fe","volume":"173","author":"Wei","year":"2005","unstructured":"Wei JT, Calhoun E, Jacobsen SJ (2005) Urologic diseases in America project: benign prostatic hyperplasia. J Urol 173: 1256\u20131261","journal-title":"J Urol"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-008-1843-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-008-1843-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-008-1843-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T10:58:53Z","timestamp":1558609133000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-008-1843-x"}},"subtitle":["Ein \u00dcberblick"],"short-title":[],"issued":{"date-parts":[[2008,8,8]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["1843"],"URL":"https:\/\/doi.org\/10.1007\/s00120-008-1843-x","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,8]]}}}